Harvard Infectious Diseases In Adults 2026

Description

Description

Include: 62(+ 4) videos + 62(+ 4) file sub vtt + 53 pdfs, size: 18.58 (+ 66.94) GB

Target Audience: infectious disease physicians, internists, hospital medicine physicians, family practice physicians, pulmonologists, critical care medicine physicians, emergency medicine physicians

1. Overview

The Harvard Infectious Diseases In Adults 2026 program provides a comprehensive, expert-led review of the most current developments in diagnosing and managing complex infectious diseases. The curriculum covers a wide array of high-yield topics, including antimicrobial stewardship, emerging fungal and viral infections, HIV management, and multidisciplinary approaches to challenging cases such as endocarditis, bone infections, and mycobacterial diseases.

Course Date: May 4, 2026 – May 8, 2026

Infectious Diseases in Adults 2026 provides state-of-the-art approaches for the prevention, diagnosis, and management of infectious diseases: common, challenging, rare, and emerging.

State-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases in Adults

Infectious Diseases in Adults 2026 is LIVE STREAMED with on-demand access available for 90 days after the course.

This comprehensive CME program, now in its 50th year, ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:

Optimal decision-making across a range of common and unusual infectious diseases
Newer antimicrobials and treatment strategies for highly resistant infections
Prevention and treatment of infections in immunocompromised hosts
Update on antifungal diagnostics and therapy
State-of-the-art and multidisciplinary approaches to common infections
Clinical approaches to complex, rare, and “don’t-miss” infections
New, evolving, emerging, and re-emerging infectious diseases
Infections in persons with substance use disorder
What’s new in HIV prevention and management
The latest on COVID-19, including long COVID
Adult vaccinations in 2026

As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.

In addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 90 days after the conclusion of the course. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 60 days of the conclusion of the course to receive CME credit.)

Highlights of the 2026 Program

Expanded Case-Based and Problem-Solving Education
The 2026 program features an expanded range of interactive, case-based, and problem-solving education. The formats are engaging, and attendees are encouraged to pose questions to our national experts in live question-and-answer sessions following the lectures and the multidisciplinary workshops.

Our speakers and panelists include not only ID experts, but those from fields such as pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine, thereby providing a 360-degree context for the understanding of ID treatment and patient care.

Our ten multidisciplinary workshops include complicated urinary tract and intra-abdominal infections, resistant Gram-positive and Gram-negative infections, management of endocarditis and cardiac device infections, musculoskeletal infections, and nontuberculous mycobacterial infections.

Treating Highly Resistant Infections, including:

MRSA and VISA (vancomycin-intermediate Staph aureus)
Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods
Carbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms
Vancomycin-resistant enterococci (VRE)
Resistant fungal infections, including Aspergillus, other molds, and resistant Candidal infections
Nontuberculous mycobacteria (NTM)

Common Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment, including:

Respiratory viral infections, including COVID-19
New and updated vaccine guidance
Infections in the expanding populations of immunocompromised hosts
Infections in persons with substance use disorder
Infections of travelers and foreign-born persons
Systemic fungal infections
Native and device-related orthopedic infections
Central nervous system (CNS) infections
Native and prosthetic valve endocarditis, and cardiac device infections
Ear, nose, and throat (ENT) and eye infections
Skin and soft tissue infections
Bronchiectasis and pneumonia
HIV and its infectious and noninfectious complications
PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection
Sexually transmitted infections (STIs), including mpox and PEP for prevention of STIs
Hepatitis B and C infections
Tick- and mosquito-borne infections
Clostridioides difficile infection, the gut microbiome, and pre- and probiotics
Complicated urinary tract infections
Intra-abdominal infections

Challenging, Rare, and Emerging Infectious Diseases, including:

Highly pathogenic avian flu
Re-emergence of vaccine-preventable diseases, including poliomyelitis
Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus
Global infectious diseases of clinical importance

Clinical Decision-Making
Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:

Selecting the best antimicrobial and duration of treatment
Rapid detection and empiric treatment of life-threatening infectious diseases
Choosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials
Optimizing empiric antimicrobial therapy: what to start, and how and when to de-escalate

Our multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:

Antimicrobial stewardship to prevent resistance and reduce cost
Early inpatient ID consultations to improve outcomes
Strategies for management of infection in persons who inject drugs (PWID)

New in 2026: Advanced Learning Modules

HIV
Mycobacterial Infections

Each of these expanded learning modules provides advanced content for learners seeking to build additional expertise in these two important areas. These modules offer on-demand, self-paced lectures as well as live Meet-the-Professors sessions, where our expert faculty discuss cases submitted by our course participants.

2. Learning Objectives

Utilize the latest strategies for the prevention, diagnosis, and management of important infectious disease syndromes in immunocompetent and immunocompromised patients
Describe updated guidelines on the treatment of infectious diseases
Summarize principles of judicious antimicrobial selection, dose, route, and duration to optimize patient outcomes while preventing resistance and lowering cost
Describe evidence-based treatments as well as new treatment paradigms for resistant organisms and difficult-to-treat infections
Recognize the role of novel, rapid diagnostics of infection and resistance in infectious disease practice
Recognize the epidemiologic risk factors for emerging infectious diseases and provide optimal empiric and target therapies for infections
Design and implement multidisciplinary care for patients in areas such as hematology oncology, solid organ transplantation, musculoskeletal infections, endocarditis, abdominal infections, and genitourinary infections

3. Target Audience

Best for infectious disease physicians and internists who want updates on antimicrobial stewardship, HIV, and managing complex infections.

Who Should Participate

Physicians, Nurse Practitioners, Physician Assistants, and Pharmacists in the fields of:

Infectious Diseases

Hospital Medicine

Internal Medicine

Family Practice

Pulmonary and Critical Care Medicine

Emergency Medicine

…and others who care for patients with infectious diseases

4. Topics

01 Advancing Patient Care Through Antimicrobial Stewardship
02 Update on Antifungal Diagnostics and Therapy
03 Plenary The Future of Global Public Health Lessons from HIV
04 Live Q&A Dr. Linda-Gail Bekker
05 Eye and ENT Infections What You Need to Know in 2026
06 Live Q&A Drs. Miriam Barshak, Nesli Basgoz, Alyssa Letourneau, and Michael Mansour
07 Multidisciplinary Panel Workshop 1 Resistant Gram-Positive Infections
08 Multidisciplinary Panel Workshop 2 Resistant Gram-Negative Infections
09 Live Q&A Drs. Alyssa Letourneau, Roby Bhattacharyya, Cecilia Li, and Tiffany Wu
10 C. difficile Update, the Gut Microbiome, and Pre- and Probiotics
11 Skin and Soft Tissue Infections Current Best Practices for Clinicians
12 Live Q&A Drs. Sandra Nelson and Elizabeth Hohmann
13 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy
14 Infections in Hematologic Malignancies and Stem Cell Transplantation
15 Flummoxing Cases in Fungal Infections
16 Live Q&A Drs. Camille Kotton, Michael Mansour, Sarah Hammond, and Sarah Turbett
17 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections
18 Updates on COVID-19, Including Long COVID
19 Navigating New Vaccines Updates and Recommendations
20 Pre- and Post-Exposure Prophylaxis for HIV and STIs
21 What’s New in the Care of People with HIV in 2026
22 Addressing the Continuing Challenges in HIV-Associated Opportunistic Infections
23 Live Q&A Drs. Rajesh Gandhi, Nesli Basgoz, Kevin Ard, and Camille Kotton
24 Self-Paced Study HIV Perinatal HIV Infection
25 Self-Paced Study HIV Perinatal Metabolic Complications of HIV
26 Self-Paced Study HIV Perinatal CROI Updates
27 Self-Paced Study HIV Perinatal HIV Resistance
28 Introduction to TB, Latent TB Infection, and Drug-Susceptible TB
29 Drug-Resistant TB and TB in Special Populations
30 Live Q&A Drs. Rocio Hurtado and Jodian Pinkney
31 Bronchiectasis and NTM Infections Anatomic and Clinical Approaches
32 The Latest on Major Respiratory Viral Infections
33 Innovations in HBV and HCV Care Updates for 2026
34 Live Q&A Drs. Nesli Basgoz, Arthur Kim, and Michael Ison
35 Live New England Journal of Medicine Clinicopathologic Conference (CPC) Please note This event will not be recorded
36 Clinical Challenges in Tropical Medicine A 2026 Review
37 Global Infectious Diseases Case-Based Updates
38 Live Q&A Dr. Edward T. Ryan
39 Multidisciplinary Panel Workshop 3 Management of Complex Nontuberculous Mycobacterial Infection (NTM) Pulmonary
40 Multidisciplinary Panel Workshop 4 Management of Complex Nontuberculous Mycobacterial Infection (NTM) Extrapulmonary
41 Live Q&A Drs. Rocio Hurtado, Michael Lanuti, Christopher Richards, Kristen Hysell, Alex Rock, and Alyssa Letourneau
42 Encephalitis and Meningitis Guidelines and Best Practices
43 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, and Rickettsia
44 Live Q&A Drs. Allan Tunkel and Kimon Zachary
45 Bone and Joint infections A Conceptual Framework
46 Staphylococcus aureus Déjà Vu All Over Again
47 Live Q&A Drs. Sandra Nelson and Henry Chambers
48 Multidisciplinary Panel Workshop 5 Native Bone Infections
49 Multidisciplinary Panel Workshop 6 Orthopedic Device Infections Prosthetic Joint Infections
50 Live Q&A Drs. Sandra Nelson, Hayden Box, F. Joseph Simeone, and Jeremy Goverman VIDEO NOT RELEASE
51 New and Emerging Viruses Clinical Insights for Frontline Providers and ID Specialists
52 KEYNOTE Polio The Unfinished Story
53 Live Q&A Drs. Martin Hirsch and David Oshinsky VIDEO NOT RELEASE
54 Intra-abdominal Infections A Conceptual Framework
55 Urinary Tract Infections A Conceptual Framework
56 Critical Care ID and Sepsis for the ID Clinician
57 Live Q&A Drs. Nesli Basgoz, Jacob Lazarus, and Lisa Bebell VIDEO NOT RELEASE
58 Multidisciplinary Workshop 7 Management of Complex Intra-abdominal Infections
59 Multidisciplinary Workshop 8 Management of Complex Urinary Tract Infections
60 Live Q&A Drs. Nesli Basgoz, Jacob Lazarus, Peter Fagenholz, Vincent Wu, Kristen Hung, and Lori Jones
61 Endocarditis and Cardiac Device Infections
62 The Syndemic of SUD and Infection Updated Approaches for 2026
63 Live Q&A Drs. Molly Paras and Jennifer Johnson
64 Multidisciplinary Workshop 9 Management of Endocarditis
65 Multidisciplinary Workshop 10 Management of Cardiac Device Infections
66 Live Q&A Drs. Molly Paras, Anne Duckles, Arminder Jassar, Shaan Khurshid, and Evin Yucel